Promedior's Grant

Promedior raised a round of funding on July 23, 2009. Investors include Qualifying Therapeutic Discovery Project.

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with exces…

Articles about Promedior's Grant: